Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alzheimer's disease: what multiphoton microscopy teaches us.

Brian J Bacskai1, Bradley T Hyman

  • 1Alzheimer's Disease Research Laboratory, Massachusetts General Hospital, Charlestown 02129, USA.

The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry
|October 11, 2002
PubMed
Summary

This article explains how a specialized imaging technique called multiphoton microscopy allows scientists to observe the development of Alzheimer's disease brain lesions in living mice over time, helping to test potential new treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reconstitution of the Alzheimer's Disease Tau Core Structure from Recombinant Tau<sup>297-391</sup> Yields Variable Quaternary Structures as Seen by Negative Stain and Cryo-EM.

Biochemistry·2023
Same author

Aberrant vascular architecture in the hippocampus correlates with tau burden in mild cognitive impairment and Alzheimer's disease.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2023
Same author

Cases of familial idiopathic normal pressure hydrocephalus implicate genetic factors in disease pathogenesis.

Cerebral cortex (New York, N.Y. : 1991)·2023
Same author

Reply: Soluble oligomers or insoluble fibrils?

Acta neuropathologica·2023
Same author

Age-Dependent Increase in Tau Phosphorylation at Serine 396 in Huntington's Disease Prefrontal Cortex.

Journal of Huntington's disease·2023
Same author

APOE2 gene therapy reduces amyloid deposition, and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease.

bioRxiv : the preprint server for biology·2023

Area of Science:

  • Neuroscience research within multiphoton microscopy imaging
  • Pathology studies of neurodegenerative disorders

Background:

Current diagnostic standards for Alzheimer's disease rely exclusively on examining brain tissue after death to identify specific pathological markers. This limitation prevents researchers from observing how these lesions form and evolve within a living brain. Prior research has shown that plaques and tangles represent the primary structural hallmarks of this neurodegenerative condition. That uncertainty drove scientists to seek non-invasive methods for real-time visualization of these microscopic features. No prior work had resolved the full natural history of these deposits in intact, living systems. This gap motivated the development of advanced optical tools capable of deep tissue penetration. Earlier imaging modalities often lacked the resolution or depth required to monitor cortical changes over extended periods. Consequently, the field required a transition toward techniques that maintain tissue integrity while providing high-resolution structural data.

Purpose Of The Study:

The aim of this review is to explain how advanced imaging techniques allow for the visualization of Alzheimer's disease pathology in living subjects. This work addresses the limitations of relying solely on postmortem tissue analysis for understanding disease progression. The authors seek to clarify how non-invasive methods provide a better understanding of the pathogenesis of this condition. This study investigates the potential for monitoring the natural history of plaques over time in transgenic mouse models. The researchers intend to describe how specific optical approaches facilitate the evaluation of antiplaque therapeutics. This review explores the technical advantages of using near-infrared light for deep cortical imaging. The motivation for this work is to highlight how real-time data can inform new paradigms for preventing or reversing brain deposits. The study aims to synthesize current knowledge regarding the application of these tools in neurodegenerative research.

Keywords:
neurodegenerationin vivo imagingcortical plaquestransgenic mouse models

Frequently Asked Questions

The researchers propose that this technique allows for the direct observation of plaque formation and the testing of antiplaque therapeutics in living transgenic mice. This method enables a longitudinal assessment of how these lesions evolve, which is not possible through static postmortem analysis.

Multiphoton microscopy utilizes near-infrared light, which is benign to living tissue and achieves greater penetration depth compared to visible or ultraviolet light sources. This specific wavelength allows for high-resolution imaging of microscopic structures deep within the cortex of the brain.

The authors state that near-infrared light is necessary because it penetrates deeper into the cortex than visible or ultraviolet light. This depth is required to capture clear images of microscopic structures located beneath the surface of the living brain.

This imaging approach relies on transgenic mice that serve as models for the disease. These animals are essential for evaluating the natural history of plaques and testing the effectiveness of various experimental treatments over time.

Related Experiment Videos

Main Methods:

Review approach involves analyzing how optical systems monitor structural changes within the cerebral cortex of living transgenic models. The authors examine the application of near-infrared light to achieve deep tissue penetration without inducing damage. This methodology focuses on the longitudinal tracking of pathological markers over extended durations. The review approach synthesizes data from studies utilizing high-resolution imaging to characterize lesion development in real time. Researchers evaluate the utility of these techniques for assessing the impact of pharmacological interventions on plaque burden. The analysis compares the limitations of static postmortem diagnostics with the advantages of dynamic in vivo observation. This review approach highlights the technical requirements for maintaining tissue viability during prolonged imaging sessions. The study design emphasizes the integration of advanced optics to visualize microscopic features deep within the brain.

Main Results:

Key findings from the literature demonstrate that this imaging modality enables the visualization of plaques deep within the cortex of living transgenic mice. The authors report that near-infrared light penetration allows for high-resolution monitoring of these structures over time. This approach facilitates the direct examination of the natural history of plaque formation in a living system. Key findings from the literature suggest that this technique is effective for evaluating the response of lesions to antiplaque therapeutics. The evidence indicates that these optical tools are benign to living tissue, preserving the integrity of the brain during the imaging process. Researchers found that longitudinal data provides a more comprehensive understanding of pathogenesis than traditional postmortem analysis. The literature confirms that these methods permit the characterization of lesions that were previously only observable after death. These results show that real-time imaging provides a robust platform for testing potential treatments in preclinical models.

Conclusions:

The authors suggest that this optical approach provides a window into the progression of neurodegenerative lesions in living subjects. Synthesis and implications indicate that longitudinal monitoring of plaque dynamics offers a clearer picture of disease pathogenesis. Researchers propose that these imaging capabilities allow for the direct assessment of therapeutic interventions aimed at clearing deposits. The evidence supports the use of transgenic mouse models to evaluate the efficacy of antiplaque strategies in real time. This review highlights how near-infrared light facilitates the study of deep cortical structures without causing damage to the tissue. The findings imply that observing the natural history of these markers is vital for developing future treatment paradigms. The authors conclude that this methodology bridges the gap between static postmortem observations and dynamic disease processes. These insights offer a framework for refining drug development pipelines targeting the early stages of cognitive decline.

The researchers measure the natural history and progression of plaques within the cortex. By monitoring these structures over time, they can evaluate how different therapeutic interventions influence the size or number of these deposits.

The authors propose that these imaging capabilities provide a better understanding of disease pathogenesis. They suggest that this knowledge is vital for creating new paradigms for preventing or reversing the accumulation of pathological deposits.